Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
---|
11/15/2006 | EP1406899B1 Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents |
11/15/2006 | EP1401434B1 Modulators of peroxisome proliferator activated receptors (ppar) |
11/15/2006 | EP1363648B1 Agastache rugosa extract having anti-inflammatory activity and anti-atherogenic activity |
11/15/2006 | EP1335919B1 Triazolo[4,5-d]pyrimidine derivatives as anti-thrombotic agents |
11/15/2006 | EP1324991B1 Compounds useful in the treatment of inflammatory diseases |
11/15/2006 | EP1323711B1 Novel phenylalanine derivatives |
11/15/2006 | EP1309557B9 Amlodipine hemimaleate |
11/15/2006 | EP1309323B1 Treatment of angiogenesis-related disorders using benzoyl phenylacetic acid derivatives |
11/15/2006 | EP1254659B1 Stable emulsion compositions |
11/15/2006 | EP1007514B1 Heterocyclic ketones as npy y5 antagonists |
11/15/2006 | EP0968206B1 N-heterocyclic derivatives as nos inhibitors |
11/15/2006 | CN1863803A 嘧啶衍生物 Pyrimidine derivatives |
11/15/2006 | CN1863800A Novel compounds that modulate PPAR type receptors, and use thereof in cosmetic or pharmaceutical compositions |
11/15/2006 | CN1863778A Compounds and methods for treating dyslipidemia |
11/15/2006 | CN1863773A 四氢吡啶衍生物 Tetrahydropyridine derivatives |
11/15/2006 | CN1863548A Methods and compositions for treating disorders of the extracellular matrix |
11/15/2006 | CN1863542A Plant seed extract composition and process for producing the same |
11/15/2006 | CN1863534A Quinazoline derivatives as inhibitors of vegf receptor tyrosine kinases |
11/15/2006 | CN1863523A Application of L-NBP in preparation of medicine for preventing and curing celebralin farction |
11/15/2006 | CN1861621A Process of preparing burdock glucoside and glucosidgen thereof |
11/15/2006 | CN1861555A Triphenylalkene derivatives and their use as selective estrogen receptor modulators |
11/15/2006 | CN1861178A Medicinal composition for treating primary hypertension and preparing method of tea agent thereof |
11/15/2006 | CN1861171A Method for preparing traditional Chinese medicine to treat apoplexia hemiplegia and said medicine |
11/15/2006 | CN1861146A Compound soft capsule 'Xueshuantong' for treating thrombus disease and its prepn. method |
11/15/2006 | CN1861142A Medicine composition for treating coronary heart disease and its prepn. method |
11/15/2006 | CN1861132A Medicine for treating ischemic cexebral apoplexia and its prepn. method |
11/15/2006 | CN1861122A Traditional Chinese medicine prepn. used for treating apoplexia and obstruction of qi in the chest, and its prepn. method |
11/15/2006 | CN1861112A Application of Qishen Yiqi dripping pills for preparing medicine to inhibit leakage of albumin |
11/15/2006 | CN1861099A 蛇油软胶囊 Snake Oil Soft Capsule |
11/15/2006 | CN1861088A Nasal drip liquor for treating rhinitis and nasosinusitis |
11/15/2006 | CN1861087A High purity wild Radix scutellariae glucoside medicine composition, and application of making medicine to treat diseases of cardiovascular and cerebrovascular |
11/15/2006 | CN1861077A Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
11/15/2006 | CN1861070A Use of tanshinone type compounds for preparing medicines to treat angiitis |
11/15/2006 | CN1860898A Fat-control tea |
11/15/2006 | CN1284851C Somatic cell derived embryonic stem cell and its differentiated cell |
11/15/2006 | CN1284793C C-aryl glucoside sglt2 inhibitors |
11/15/2006 | CN1284783C Substituted nitrogen contg. heterocycles as inhibitors of P38 progein kinase |
11/15/2006 | CN1284589C Medicine for treating acute brain blood vessel disease and its preparation method |
11/15/2006 | CN1284568C Chinese medicine preparation for treating coronary heart disease and rheumatic heart disease |
11/15/2006 | CN1284560C Multifunctional external-applied ointment and production thereof |
11/15/2006 | CN1284551C Chinese medicinal preparation and preparing method for acute cerebral infarction |
11/15/2006 | CN1284544C Application of Hibiscus sabdariffa Linn extractive in preparing medicine for inhibiting cardiac and cerebral vascular diseases |
11/15/2006 | CN1284541C Magnesium, potassium and calcium mixture and its usage |
11/15/2006 | CN1284534C Aromatic turmeric oil extracts and its preparing process and medicinal composition containing the same |
11/15/2006 | CN1284525C Production method of disodium adenosine triphosphate magnesium chloride injection |
11/15/2006 | CN1284522C Dextrose and insulin fluid formulation for intravenous infusion |
11/14/2006 | US7135600 Selective beta 2-adrenoreceptor agonists; rapid onset of action, long duration; such as 3-(4-{[6-{(-2-hydroxy-2-[4-hydroxy-3-(hydroxymethyl)phenyl]ethyl}amino)hexyl]oxy}butyl)benzenesulfonamide; synthesis |
11/14/2006 | US7135587 Such as 3-biphenyl-4-yl-3-(2-(3-(pyridin-2-ylamino)pro-poxycarbonylamino) -ethanoylamino)propionic acid; thromboses, cardiac infarction, coronary heart disease, arteriosclerosis, inflammation, tumors. osteoporosis, infections, restenosis |
11/14/2006 | US7135568 Substituted pyrazolopyrimidines and thiazolopyrimidines |
11/14/2006 | US7135502 Colchinol derivatives as vascular damaging agents |
11/14/2006 | US7135497 Spinal administration of at least one beta 2 adrenergic agonist such as clenbuterol and salbutamol; neurodegenerative diseases; improved locomotor function and neuromuscular strength |
11/14/2006 | US7135491 5-Aryltetrazole compounds and uses thereof |
11/14/2006 | US7135486 Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and the use thereof |
11/14/2006 | US7135474 In combination with organic nitrate or nitric oxide donors or inhibitors of cyclic GMP metabolism; erectile dysfunction or female sexual dysfunction |
11/14/2006 | US7135473 Cyclic diamine compound with condensed-ring groups |
11/14/2006 | US7135471 Aryl oximes |
11/14/2006 | US7135466 used in the treatment of diseases mediated by the autophosphorylation of a PDGF receptor, specifically, compounds which can inhibit neointima formation hypertrophy. |
11/14/2006 | US7135464 Method of administering decitabine |
11/14/2006 | US7135453 Reagents and methods for smooth muscle therapies |
11/14/2006 | US7135320 Adaptor protein FRS2 and related products and methods |
11/14/2006 | US7135279 4-alpha glucotransferases; enzymes inhibitors; enantimorphs; adrenergic blocking agents; proteases; superoxide dismutases; carbonic anhydrases |
11/14/2006 | US7135189 Compositions and techniques for localized therapy |
11/14/2006 | CA2379572C Polymorphic salt |
11/14/2006 | CA2342271C Gem substituted hydroxamic acids |
11/14/2006 | CA2340320C Use of an angiogenic factor for the treatment of microascular angiopathies |
11/14/2006 | CA2263846C Novel pyranoside derivatives |
11/14/2006 | CA2128955C Tricyclic benzazepine vasopressin antagonists |
11/14/2006 | CA2111386C Substituted benzoylguanidines, process for their preparation, their use as pharmaceutical or diagnostic, and pharmaceutical containing them |
11/09/2006 | WO2006118341A1 Novel lactam compound |
11/09/2006 | WO2006118328A1 Degranulation inhibitor |
11/09/2006 | WO2006118320A1 Thienopyrimidone compound |
11/09/2006 | WO2006118316A1 Inhibitor for lipid accumulation in liver |
11/09/2006 | WO2006118313A1 Novel polypeptide and use thereof |
11/09/2006 | WO2006118299A1 Gpcr inhibitor |
11/09/2006 | WO2006118256A1 2-aminoquinazoline derivatives |
11/09/2006 | WO2006118210A1 Method of preventing dihydropyridine compound from degradation |
11/09/2006 | WO2006118131A1 Peptide having anti-anxiety effect and method for screening thereof |
11/09/2006 | WO2006117668A1 Fatty acid analogues, i.e. dha derivatives for uses as a medicament |
11/09/2006 | WO2006117664A1 New dha derivatives and their use as medicaments |
11/09/2006 | WO2006117183A1 3 -m0n0- and 3 , 5-disubstituted piperidine derivatives as renin inhibitors |
11/09/2006 | WO2006117170A1 Improved method for preparing ginkgo extracts having a reduced content of polycyclic aromatic hydrocarbons |
11/09/2006 | WO2006117165A2 Means and methods for the treatment of head injuries and stroke |
11/09/2006 | WO2006117076A1 Use of indolin-phenylsulfonamide derivatives |
11/09/2006 | WO2006117075A1 Use of indolin-phenylsulfonamide derivatives |
11/09/2006 | WO2006116949A1 A new bacillus subtilis strain and its use in preparing medicine for treating thrombosis |
11/09/2006 | WO2006116815A1 Composition for the control of cholesterol levels |
11/09/2006 | WO2006116814A1 Composition and uses thereof |
11/09/2006 | WO2006100021A8 Use of the mst protein for the treatment of a thromboembolic disorder |
11/09/2006 | WO2006099940A8 Substituted, bicyclic 8-pyrrolidino-benzimidazoles, method for their production and their use as medicaments |
11/09/2006 | WO2005097087A3 Merged ion channel modulating compounds and uses thereof |
11/09/2006 | US20060252943 Chemical process |
11/09/2006 | US20060252839 Cyclopenteneones for antiischemic agents, antiinflammatory agents and aging resistance |
11/09/2006 | US20060252833 Improve efficiency when administered with conventional drugs; side effect reduction; Parkinson's disease therapy; administering a fatty acid |
11/09/2006 | US20060252827 Therapeutic use of of acyglycerols and the nitrogen-and sulphur-containing analogues thereof |
11/09/2006 | US20060252814 Formulation comprising a betablocker and optionally a cholestrol-lowering agent |
11/09/2006 | US20060252810 e.g. 5-(4-Fluorophenyl)-4-(4-pyridinyl)imidazole-2-thio-3-propyl-N-phthalimide; immunomodulating and cytokine-release-inhibiting action; antiinflammatory agent |
11/09/2006 | US20060252806 synergistic use of angiotensin II receptor antagonist like (5-methyl-2-oxo-1,3-dioxolen-4-yl)methyl 4-(1-hydroxy-1-methylethyl)-2-propyl-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]imidazol-5-carboxylate with the calcium channel blockers; calcium channel blockers containing 1,4-dihydropyridine group |
11/09/2006 | US20060252805 synergistic use of angiotensin II receptor antagonist like (5-methyl-2-oxo-1,3-dioxolen-4-yl)methyl 4-(1-hydroxy-1-methylethyl)-2-propyl-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]imidazol-5-carboxylate with the calcium channel blockers; calcium channel blockers containing 1,4-dihydropyridine group |
11/09/2006 | US20060252799 Benzo (F) insoindol derivatives and their use as EP4 receptor ligands |
11/09/2006 | US20060252797 Receptor regulator |